Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 16419, Korea.
Single Cell Network Research Center, Sungkyunkwan University School of Medicine, Suwon 16419, Korea.
Int J Mol Sci. 2020 Apr 9;21(7):2609. doi: 10.3390/ijms21072609.
Dysregulation of epigenetic machinery can cause a variety of neurological disorders associated with cognitive abnormalities. In the hippocampus of postmortem Schizophrenia (SZ) patients, the most notable finding is the deregulation of GAD67 along with differential regulation of epigenetic factors associated with glutamate decarboxylase 67 (GAD67) expression. As we previously reported, ErbB3-binding protein 1 (EBP1) is a potent epigenetic regulator. EBP1 can induce repression of Dnmt1, a well-studied transcriptional repressor of GAD67. In this study, we investigated whether EBP1 contributes to the regulation of GAD67 expression in the hippocampus, controlling epigenetic machinery. In accordance with SZ-like behaviors in mice, heterozygous deletion of EBP1 led to a dramatic reduction of GAD67 expression, reflecting an abnormally high level of Dnmt1. Moreover, we found that EBP1 binds to the promoter region of HDAC1, which leads to histone deacetylation of GAD67, and suppresses histone deacetylase 1 (HDAC1) expression, inversely mirroring an unusually high level of HDAC1 in mice. However, EBP1 mutant (p.Glu 183 Ter) found in SZ patients did not elevate the expression of GAD67, failing to suppress Dnmt1 and/or HDAC1 expression. Therefore, this data supports the hypothesis that a reduced amount of EBP1 may contribute to an etiology of SZ due to a loss of transcriptional inhibition of epigenetic repressors, leading to a decreased expression of GAD67.
表观遗传机制的失调可导致多种与认知异常相关的神经紊乱。在精神分裂症(SZ)患者死后的海马体中,最显著的发现是 GAD67 的失调以及与谷氨酸脱羧酶 67(GAD67)表达相关的表观遗传因子的差异调节。正如我们之前所报道的,表皮生长因子受体结合蛋白 1(EBP1)是一种有效的表观遗传调节剂。EBP1 可以诱导 Dnmt1 的抑制,Dnmt1 是 GAD67 的一种研究充分的转录抑制剂。在这项研究中,我们研究了 EBP1 是否有助于调节海马体中的 GAD67 表达,从而控制表观遗传机制。与 小鼠的 SZ 样行为一致,EBP1 的杂合缺失导致 GAD67 的表达显著减少,反映出 Dnmt1 的异常高水平。此外,我们发现 EBP1 与组蛋白去乙酰化酶 1(HDAC1)的启动子区域结合,导致 GAD67 的组蛋白去乙酰化,并抑制 HDAC1 的表达,这与 小鼠中 HDAC1 的异常高水平相反。然而,在 SZ 患者中发现的 EBP1 突变(p.Glu183Ter)并没有提高 GAD67 的表达,不能抑制 Dnmt1 和/或 HDAC1 的表达。因此,这些数据支持了这样一种假设,即由于表观遗传抑制剂的转录抑制丧失,EBP1 含量的减少可能导致 SZ 的发病机制,导致 GAD67 的表达减少。